131 related articles for article (PubMed ID: 17630191)
21. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro.
Carter SL; Müller M; Manders PM; Campbell IL
Glia; 2007 Dec; 55(16):1728-39. PubMed ID: 17902170
[TBL] [Abstract][Full Text] [Related]
22. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
23. Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis.
De Paula ML; Rodrigues DH; Teixeira HC; Barsante MM; Souza MA; Ferreira AP
Int Immunopharmacol; 2008 Sep; 8(9):1291-7. PubMed ID: 18602076
[TBL] [Abstract][Full Text] [Related]
24. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
25. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking.
Pedersen LB; Nashold FE; Spach KM; Hayes CE
J Neurosci Res; 2007 Aug; 85(11):2480-90. PubMed ID: 17600374
[TBL] [Abstract][Full Text] [Related]
26. (5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide derivative, prevents experimental autoimmune encephalomyelitis via inhibiting T cell activation.
Fu YF; Zhu YN; Ni J; Zhong XG; Tang W; Zhou R; Zhou Y; Dong JR; He PL; Wan H; Li YC; Yang YF; Zuo JP
J Neuroimmunol; 2006 Jun; 175(1-2):142-51. PubMed ID: 16712960
[TBL] [Abstract][Full Text] [Related]
27. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
[TBL] [Abstract][Full Text] [Related]
28. In vivo administration of plasmid DNA encoding recombinant immunotoxin DT390-IP-10 attenuates experimental autoimmune encephalomyelitis.
Chen W; Li H; Jia Y; Lv M; Li M; Feng P; Hu H; Zhang L
J Autoimmun; 2007 Feb; 28(1):30-40. PubMed ID: 17267177
[TBL] [Abstract][Full Text] [Related]
29. Suppression of experimental autoimmune encephalomyelitis by ghrelin.
Theil MM; Miyake S; Mizuno M; Tomi C; Croxford JL; Hosoda H; Theil J; von Hörsten S; Yokote H; Chiba A; Lin Y; Oki S; Akamizu T; Kangawa K; Yamamura T
J Immunol; 2009 Aug; 183(4):2859-66. PubMed ID: 19620309
[TBL] [Abstract][Full Text] [Related]
30. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis.
Brown DA; Sawchenko PE
J Comp Neurol; 2007 May; 502(2):236-60. PubMed ID: 17348011
[TBL] [Abstract][Full Text] [Related]
31. Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine.
Nizri E; Irony-Tur-Sinai M; Faranesh N; Lavon I; Lavi E; Weinstock M; Brenner T
J Neuroimmunol; 2008 Oct; 203(1):12-22. PubMed ID: 18692909
[TBL] [Abstract][Full Text] [Related]
32. Methadone diminishes neuroinflammation and disease severity in EAE through modulating T cell function.
Kafami L; Etesami I; Felfeli M; Enayati N; Ghiaghi R; Aminian A; Dehpour A
J Neuroimmunol; 2013 Feb; 255(1-2):39-44. PubMed ID: 23177720
[TBL] [Abstract][Full Text] [Related]
33. Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors.
Nizri E; Hamra-Amitay Y; Sicsic C; Lavon I; Brenner T
Neuropharmacology; 2006 Apr; 50(5):540-7. PubMed ID: 16336980
[TBL] [Abstract][Full Text] [Related]
34. A sphingosine-1-phosphate receptor 1-directed agonist reduces central nervous system inflammation in a plasmacytoid dendritic cell-dependent manner.
Galicia-Rosas G; Pikor N; Schwartz JA; Rojas O; Jian A; Summers-Deluca L; Ostrowski M; Nuesslein-Hildesheim B; Gommerman JL
J Immunol; 2012 Oct; 189(7):3700-6. PubMed ID: 22933630
[TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory effects of levetiracetam in experimental autoimmune encephalomyelitis.
Thöne J; Ellrichmann G; Faustmann PM; Gold R; Haghikia A
Int Immunopharmacol; 2012 Sep; 14(1):9-12. PubMed ID: 22691576
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo immunopharmacological profile of Sch 40120.
Smith SR; Watnick AS; Kung T; Siegel MI
Immunopharmacol Immunotoxicol; 1993 Jan; 15(1):13-44. PubMed ID: 8450179
[TBL] [Abstract][Full Text] [Related]
37. In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine.
Coe JW; Vetelino MG; Bashore CG; Wirtz MC; Brooks PR; Arnold EP; Lebel LA; Fox CB; Sands SB; Davis TI; Schulz DW; Rollema H; Tingley FD; O'Neill BT
Bioorg Med Chem Lett; 2005 Jun; 15(12):2974-9. PubMed ID: 15908213
[TBL] [Abstract][Full Text] [Related]
38. Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice.
Wang J; Chen F; Zheng P; Deng W; Yuan J; Peng B; Wang R; Liu W; Zhao H; Wang Y; Wu G
Exp Neurol; 2012 Jul; 236(1):79-87. PubMed ID: 22524989
[TBL] [Abstract][Full Text] [Related]
39. Suppression of encephalitogenic T-cell responses by cilostazol is associated with upregulation of regulatory T cells.
Wang S; Yan C; Xu H; Zhao X; Han Y
Neuroreport; 2010 Jun; 21(9):629-35. PubMed ID: 20473232
[TBL] [Abstract][Full Text] [Related]
40. Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107.
Mizrachi T; Marsha O; Brusin K; Ben-David Y; Thakur GA; Vaknin-Dembinsky A; Treinin M; Brenner T
J Neuroinflammation; 2021 Apr; 18(1):99. PubMed ID: 33902624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
